GRP
BBIO icon

Global Retirement Partners’s BridgeBio Pharma BBIO Stock Holding History

Global Retirement Partners’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$38.9K Buy
509
+372
+272% +$24.4K ﹤0.01% 2501
2025
Q3 		$7.12K Hold
137
– – ﹤0.01% 2836
2025
Q2 		$5.92K Buy
+137
New +$4.98K ﹤0.01% 2835
2024
Q4 		$3.98K Sell
145
-1,539
-91% -$39.8K ﹤0.01% 2788
2024
Q3 		$42.9K Sell
1,684
-654
-28% -$17.2K ﹤0.01% 1630
2024
Q2 		$59.2K Buy
2,338
+2,238
+2,238% +$61.2K ﹤0.01% 1450
2024
Q1 		$3.09K Sell
100
-200
-67% -$6.8K ﹤0.01% 2580
2023
Q4 		$11.3K Buy
300
+200
+200% +$6.01K ﹤0.01% 2027
2023
Q3 		$2.4K Hold
100
– – ﹤0.01% 2468
2023
Q2 		$1.72K Hold
100
– – ﹤0.01% 2598
2023
Q1 		$1.44K Hold
100
– – ﹤0.01% 2610
2022
Q4 		$762 Hold
100
– – ﹤0.01% 2662
2022
Q3 		$1K Hold
100
– – ﹤0.01% 2382
2022
Q2 		$1K Hold
100
– – ﹤0.01% 2352
2022
Q1 		$1K Buy
+100
New +$1.03K ﹤0.01% 2314
2021
Q4 		– Sell
-100
Closed -$5K – 376
2021
Q3 		$5K Hold
100
– – ﹤0.01% 1596
2021
Q2 		$6K Hold
100
– – ﹤0.01% 1509
2021
Q1 		$6K Buy
+100
New +$6.54K ﹤0.01% 1414

Other funds holding BBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's BBIO Position: Q4 2025 in Review

Global Retirement Partners increased its BridgeBio Pharma (BBIO) stake by 272% in Q4 2025, buying an estimated $24.4K and bringing the position to 509 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Global Retirement Partners first reported a position in BBIO in Q1 2021 and has held it in 18 quarters since. The position peaked at $59.2K in Q2 2024. 432 funds tracked by Wall St. Rank hold BBIO as of Q4 2025.

  • Global Retirement Partners held 509 shares of BridgeBio Pharma worth $38.9K as of Q4 2025.
  • Global Retirement Partners bought 372 BridgeBio Pharma shares in Q4 2025, an estimated $24.4K.
  • BridgeBio Pharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2501 holding.
  • Global Retirement Partners first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 18 quarters since.
  • Global Retirement Partners's BridgeBio Pharma position peaked at $59.2K in Q2 2024.
  • 432 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.